Objective: To update the prior systematic review from studies published in the past 9 years that examine the effects of condom social marketing (CSM) programs on condom use in low-and middle-income countries.
Introduction
Condom social marketing (CSM) has historically been a large component of the HIV prevention response globally, and CSM programs have been clearly shown to increase condom sales. 1 However, there is a growing gap between demand for condoms and their availability in settings with a high burden of HIV. Despite the large allocations of funds over the years dedicated to CSM, there is now declining donor support. 2 In addition, studies of the impact of CSM on condom use are quite limited, 3 and there is also a lack of studies assessing the impact of free condom distribution on condom use. 4 Thus, assessing the impact of CSM programs on condom use is important. In 2012, we published a systematic review and meta-analysis in the Bulletin of the World Health Organization of the effect of CSM programs on condom use conducted in low-and middle-income countries and published between 1990 and 2010 5 to provide policy guidance to program funders and intervention implementers.
Objective
Our objective for the present study was to update our previous systematic review on CSM for HIV prevention in low-and middle-income countries to examine the evidence base of the efficacy of CSM and examine the strength of rigor of the extant literature, now including studies published since 2010. This update occurs nearly a decade after our initial review was published.
Methods

Data Sources
We searched PubMed, CINAHL, PsycINFO, Sociological Abstracts, and EMBASE using the following updated search terms: (marketing OR sale* OR sold) AND (condom* OR contraceptive*) AND (HIV OR AIDS). We also updated hand searching of 4 journals (AIDS, AIDS and Behavior, AIDS Care, and AIDS Education and Prevention).
Inclusion and Exclusion Criteria
We conducted an updated systematic review following our previous methods 5 to identify studies published since 2010, the cutoff date for the prior analysis. Our study procedures adhere to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. 6 Studies were included if they (a) were conducted in a low-or middle-income country as defined by the World Bank, (b) evaluated a CSM intervention, (c) conducted analyses across preintervention to postintervention exposure or across multiple study arms, (d) measured condom use behavior, and (e) specifically sought to prevent HIV transmission. In addition, we defined CSM as having the following characteristics: (a) condoms were sold, (2) there was a local brand name(s) developed for the condoms, and (3) condoms were marketed with a special campaign (such as using media to promote sales). Our previous search included articles published between January 1990 and March 2010; we updated this search for articles published through January 16, 2019.
Data Extraction
We screened search results in a 2-stage process, first by a single reviewer looking at title and abstract to exclude citations clearly not meeting the inclusion criteria and then reviewed by 2 study staff independently assessing title and abstract for inclusion. Two reviewers then read the full text of potentially includable articles. We made final decisions on article inclusion after full-text review. Two reviewers independently extracted key data, and coding differences were resolved through discussion and consensus. Data were extracted on 16 content areas: (1) citation information, (2) study inclusion criteria, (3) study methods, (4) study population characteristics, (5) setting, (6) sampling, (7) study design, (8) unit of analysis, (9) loss to follow-up rates, (10) study group (arms or comparison groups) characteristics, (11) intervention characteristics, (12) intervention topic-specific questions, (13) outcome measures, (14) eligible outcome results, (15) risk of bias, 7 and (16) additional information (costs, limitations, potential harms, and community acceptance).
Our standardized methods require that all outcome variables reported in a study be noted, but detailed results are only recorded for those outcomes with either a pre/post or between-study group comparison. All eligible outcome results are coded, including subgroup presentation of results (such as by gender) even when aggregated results are also presented. After the 2 coders independently coded the citation, project staff resolve any intercoder discrepancies, including correction for data entry error and identification of different interpretations in the presentation of results. Senior staff resolve any remaining discrepancies in consultation with the study principal investigator and other senior collaborators. When needed, attempts are made to contact authors to resolve differences. Once all discrepancies are resolved, data from all coding forms are double entered into a database and later transferred to a statistical database. Detailed records are kept on the reason for discrepancies across coders and how they were resolved.
Data Synthesis
We standardized effect size estimates from study reports to the common metric of an odds ratio since all studies compared 2 groups and reported dichotomous outcomes. We utilized standard meta-analytic methods to derive standardized effect size estimates, 8 and we hand-calculated effect sizes as needed. All studies identified for this analysis reported effect sizes as the proportion of sexually active participants who used, or did not use, a condom with various sexual partners. Most studies report multiple end point measures. We specifically sought to examine the impact of HIV-related CSM programs on condom use rates. Thus, we focused our analysis only on condom use behaviors and not such factors as intentions to use condoms or attitudes toward condoms. We defined our primary outcome for analysis as condom use in the last sexual encounter but also included analyses on a composite of all condom use outcomes.
Results
Results of our search for our prior published review 5 and update are summarized in Figure 1 . Search results are disaggregated by time period. Ultimately, 6 studies with a combined sample size of 23 048 met the inclusion criteria for the quantitative synthesis. [9] [10] [11] [12] [13] [14] All studies included in the quantitative analyses came from the initial review for the dates 1990 to 2010. For studies published since 2010 through January 2019, we identified 518 unique citations that would possibly meet the inclusion criteria. Of these, 328 were excluded at the first stage of screening and 186 were excluded at the second level of screening by 2 independent reviewers. Of the 4 remaining articles which were pulled for full-text review, 3 [15] [16] [17] were excluded for not having pre/post or multiarm comparisons and 1 18 was excluded for not having study outcomes meeting the inclusion criteria. We ultimately found no new articles meeting our inclusion criteria with sufficient rigor and measurement of condom use since the initial review almost a decade ago. 5 In a meta-analysis from the earlier analysis, the random-effects pooled odds ratio for condom use was 2.01 (95% confidence interval [CI]: 1.42-2.84) for the most recent sexual encounter and 2.10 (95% CI: 1.51-2.91) for a composite of all condom use outcomes. The review found that the rigor of extant studies was weak. None of the studies randomly assigned participants to the intervention, 2 of the 6 studies had no control/comparison group, none followed a cohort, and only half measured the study end point from before to after intervention delivery.
Conclusions
Condom social marketing has historically been a mainstay of HIV public health interventions, yet the evidence base for impact of CSM on actual condom use is limited, and no studies have been published meeting our minimum inclusion criteria since 2010. The original meta-analysis analysis we published in 2012 (spanning evidence from 1990 through 2010) showed positive effects of CSM on condom use, but the number and rigor of studies was a limitation in drawing strong conclusions. We found no new articles meeting our criteria since our last review. The findings from our previous meta-analysis are thus not altered, other than to say that the available evidence is now more out of date. There is evidence that CSM can increase condom use, but the evidence comes from a limited number of older studies with weak rigor. Moreover, policy makers and practitioners in the field of HIV prevention rely on rigorous program evaluations to decide which components of an overall program to prioritize. The lack of more current efficacy data potentially limits support for CSM, especially in an era marked by growing support for pharmaceutical-based interventions such as antiretroviral treatment and pre-exposure prophylaxis. In light of the growing gap in funding for global condom distribution, 19 there is a need for more rigorous evaluations of the impact of CSM on condom use.
